: SGMO

Sangamo Biosciences, Inc. (NASDAQ: SGMO)

Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of zinc finger DNA-binding proteins for gene regulation and gene modification in the United States.